Package Leaflets (PL) for Human medicinal products

The package leaflet (PL) provides users with information about the medicinal product and its correct use. The package leaflets contain instructions in both Finnish and Swedish.

The package leaflets can be searched from alphabetical list, with the name, marketing authorisation number and the Anatomical Therapeutic Chemical, i.e. ATC Code of the Summary of Product Characteristics, SPC.

The package leaflets processed as part of the EU centralised marketing authorisation procedure are published by the European Medicines Agency, EMA. Fimea's service contains links to the documents on medicinal products (EPAR PI) on the EMA website. Drugs belonging to the centralised authorisation procedure can be searched in Fimea's service by using an alphabetical list or by entering the product name or ATC code.

The material being published is not necessarily complete or up-to-date due to the technical quality of files submitted to the Finnish Medicines Agency Fimea or earlier to the National Agency for Medicines and the delays in delivery. For this reason, Fimea cannot guarantee that the document on the Internet fully complies with the summary of product characteristics and package leaflet officially approved by a desicion for a marketing authorisation. Only the hard copies of the SPCs and the PLs, which are in accordance with the marketing authorisation, are conclusive.

Search with the first character of the name of the medicinal product: p

Product Information Leaflets 1 - 30 of 387
1  2  3  4  5  6  7  8  9  10  11  12  13  |  Next 30   >
SPC	Status for supply	Name of the medicinal product
SPC	Resepti	Pabal 100 mikrog - ml injektioneste, liuos PL 2023-06-01
SPC	Resepti	Pacligen 6 mg-ml infuusiokonsentraatti, liuosta varten PL 2023-02-21
SPC	Resepti	Paclitaxel Accord 6 mg_ml infuusiokonsentraatti, liuosta varten PL 2023-09-04.docx
SPC	Resepti	Paclitaxel Fresenius Kabi 6 mg-ml infuusiokonsentraatti, liuosta varten PL 2022-09-01
		European Medicines Agency's website: Padcev - EMA: EPAR PI Finnish Swedish
SPC	Resepti	Palexia Depot 25 mg depottabletti PL 2020-03-27
SPC	Resepti	Palexia Depot 50 mg, 100 mg, 150 mg, 200 mg, 250 mg depottabletti PL 2020-03-27
SPC	Resepti	Palexia depot 50 mg, 100 mg, 150 mg, 200 mg, 250 mg PIL 2010-11-15
		European Medicines Agency's website: Palforzia - EMA: EPAR PI Finnish Swedish
SPC	Resepti	Paliperidone ratiopharm 25 mg, 50 mg, 75 mg, 100 mg, 150 mg ja 150mg+100mg injektioneste, depotsuspensio PL 2024-03-01
SPC	Resepti	Paliperidone Stada 25 mg, 50 mg, 75 mg, 100 mg, 150 mg injektioneste, depotsuspensio, esitäytetty ruisku PL 2024-04-05
SPC	Resepti	Palladon 1.3 mg, 2.6 mg kapseli, kova PL 2024-09-11
SPC	Resepti	Palladon 4 mg, 8 mg, 16 mg, 24 mg depotkapseli, kova PL 2024-09-11
SPC	Resepti	Palladon 50 mg-ml injektio-/infuusioneste, liuos PL 2024-09-11
SPC	Resepti	Palmeux 25 mg, 50 mg, 75 mg, 100 mg, 150 mg injektioneste, depotsuspensio, esitäytetty ruisku PL 2024-05-22
		European Medicines Agency's website: Palonosetron Accord - EMA: EPAR PI Finnish Swedish
SPC	Resepti	Palonosetron Fresenius Kabi 250 mikrog injektioneste, liuos PL 2021-04-13
SPC	Resepti	Palonosetron Macure 250 mikrog injektioneste PL 2018-09-26
SPC	Resepti	Palonosetron Reig Jofre 250 mikrog injektioneste PL 2022-06-03
SPC	Resepti	Palonosetron Stada 250 mikrog injektioneste PL 2018-03-05
		European Medicines Agency's website: Palynziq - EMA: EPAR PI Finnish Swedish
SPC	Resepti	Pamifos 3 mg - ml infuusiokonsentraatti, liuosta varten PL 2022-04-27
SPC	Resepti/itsehoito	Pamol 1000 mg tabletti OTC PL 2021-09-01
SPC	Resepti/itsehoito	Pamol 1000 mg tabletti PL 2021-09-01
SPC	Resepti	Pamol 24 mg-ml oraalisuspensio PL 2024-05-15
SPC	Resepti	Pamol 500 mg tabletti PL 2023-02-20
SPC	Itsehoito	Pamol 500 mg tabletti PL 2023-02-21 (OTC)
SPC	Itsehoito	Pamol F 125 mg, 250 mg dispergoituva tabletti PL 2022-09-19
SPC	Resepti	Pamol F 500 mg tabletti, suussa hajoava PL 2022-09-19
SPC	Itsehoito	Pamolhot-C 750 mg-300 mg porejauhe PL 2021-09-01.docx
1  2  3  4  5  6  7  8  9  10  11  12  13  |  Next 30   >